Pancreatic cancer is the third leading cause of cancer death in the U.S. That’s due in part to the limited testing available for early detection. Now researchers at Johns Hopkins say they’ve made a ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.